Izindaba Zenkampani
-
I-FDA ivuma i-ibutinib yokwelapha isifo esingamahlalakhona se-graft-versus-host (cGVHD) ezinganeni
Ngomhlaka-24 Agasti 2022, i-US Food and Drug Administration (FDA) yavuma i-ibutinib yokwelapha iziguli zezingane ezingaphezu konyaka owodwa ezinesifo esingamahlalakhona se-graft-versus-host (cGVHD) ezithola ukwelashwa ngemuva kokwehluleka kokwelashwa kwe-systemic kwemigqa eyodwa noma eminingi. Isibonakaliso esivunyelwe ikakhulukazi...Funda kabanzi -
Izindaba Ezinkulu! I-SyncoZymes (Shanghai) Co., Ltd. Izinto zokuqala zokusetshenziswa ze-NMN emhlabeni ziphumelele isitifiketi se-FDA NDI.
Ngemva kokubuyekezwa okuqinile yikomidi lochwepheshe lenhlangano enegunya le-US FDA (US Food and Drug Administration), ngoMeyi 17, 2022, i-SyncoZymes (Shanghai) Co., Ltd. yamukele ngokusemthethweni incwadi yokuqinisekisa ye-FDA (AKL): Izinto zokusetshenziswa ze-NMN ziphumelele ngempumelelo i-ND...Funda kabanzi -
I-Zhejiang Syncozymes Biopharmaceutical Co., Ltd. Iphrojekthi ye-enzyme catalysis idlulise ukubuyekezwa kokuqala kohlelo olubalulekile locwaningo nentuthuko yeSifundazwe saseZhejiang
Ngo-Agasti 2020, iphrojekthi ethi “Bio-enzyme Library Development and Green Catalytic Synthesis Application” yeZhejiang Shangke Biopharmaceutical Co., Ltd. yaphasisa isibuyekezo sokuqala sohlelo lweZhejiang Provincial Key R&D loMnyango Wezesayensi Nobuchwepheshe Wesifundazwe saseZhejiang...Funda kabanzi -
Izindaba ezinkulu: I-Syncozymes inomkhiqizo waminyaka yonke wamathani ayi-100 ochungechunge lwe-coenzyme NMN/NADH/NAD. Lezi zithako zizofakwa ekukhiqizweni
Ukukhiqizwa kwaminyaka yonke kwe-Syncozymes kwamathani ayi-100 emikhiqizo yochungechunge lwe-coenzyme NMN/NADH/NAD kuzoqala ukukhiqizwa ngokusemthethweni ngo-Okthoba kulo nyaka! (Zhejiang Syncozymes Bio-pharmaceutical Co., Ltd.) Njengoba...Funda kabanzi -
Izindaba ezinhle: I-Syncozymes iqashelwe njengephrojekthi yokuguqula impumelelo yobuchwepheshe obuphezulu
Ngomhlaka-5 Januwari 2021, iShangke Biopharmaceutical (Shanghai) Co., Ltd. yanikezwa iphrojekthi yokuguqulwa kwempumelelo ye-Shanghai High-tech Achievement Transformation Project ethi "(S)-1-tert-butoxycarbonyl-3-hydroxypiperidine". Njengebhizinisi likazwelonke elinobuchwepheshe obuphezulu, iSuntech Biotech ihlala isebenzisa ubuchwepheshe be-biotechnology ukuze ifunde...Funda kabanzi -
[Ngesikhathi se-Expo]: I-Syncozymes iwine isihloko seqembu lokuqala lamabhizinisi ukuzinza ku-“Global Matchmaking Club”
Ipulatifomu yokwenza imincintiswano ye-"Global Matchmaking Club" yathuthukiswa ngokuzimela yi-ICBC futhi ivulekele amabhizinisi omhlaba mahhala. Imisebenzi yokufanisa neminye imisebenzi eyinhloko. Selokhu ipulatifomu yasungulwa isikhathi esingaphezu kwezinyanga ezimbili, idonsele...Funda kabanzi -
I-Shangke Bio kanye ne-Zhejiang Supor Pharmaceutical Co., Ltd. bahlanganyele ku-2020 Nanjing API CHINA API Exhibition futhi benza umbiko okhethekile wezemfundo nge-NMN
Ngomhlaka-14 Okthoba 2020, umbukiso wama-85 we-China International Pharmaceutical API/Intermediate/Packaging/Equipment Fair (obizwa ngokuthi i-API China API) wavulwa eNanjing International Expo Center. I-Shangke Bio kanye ne-Zhejiang Supor Pharmaceutical Co., Ltd. bahlanganyele eNanjing ka-2020...Funda kabanzi -
[Izindaba ezinhle] Imikhiqizo ye-NMN ye-Syncozymes iphumelele isitifiketi sokuphepha se-SELF GRAS e-United States.
NgoSepthemba 2020, imikhiqizo ye-NMN ye-Syncozymes yaphasa isitifiketi sokuphepha se-SELF GRAS (US Safety Index for Evaluation of Food Additives). I-NMN ibizwe ngokuthi “i-elixir” ngumphakathi, futhi umsebenzi wayo oyinhloko ukulungisa i-DNA, amaseli anempilo, kanye nokuqeda izifo ezahlukahlukene ezibangelwa ...Funda kabanzi -
Izinto zokusetshenziswa ze-NMN ze-Syncozymes ziphumelele i-“Acute Oral Toxicity Test”
Ukuqubuka kwamuva komqondo "womuthi wokuphila isikhathi eside" i-NMN kubangele ukushaqeka emakethe yezimali. Maphakathi noJulayi, isitoko somqondo "womuthi wokuphila isikhathi eside wabantu abadumile be-inthanethi" i-NMN saba yihhashi elimnyama emakethe. Amasheya ezinkampani ezihlobene nawo avalwe ngemuva ...Funda kabanzi